William Boshoven

Spectrum Health

Papers

1

Total Citations

20

H-Index

1

About

William Boshoven is a clinical researcher whose work centers on the early detection and mitigation of acute kidney injury (AKI), particularly in the context of urological surgery. His primary contributions lie in the evaluation of novel urinary biomarkers for predicting renal damage before standard clinical indicators arise. In his most-cited study, a 2018 feasibility investigation, Boshoven demonstrated that specific urinary biomarkers can serve as early, non-invasive predictors of AKI following partial nephrectomy—a critical advancement for preserving long-term kidney function in patients undergoing nephron-sparing surgery. This work, which has garnered 20 citations, underscores his commitment to translating molecular diagnostics into practical perioperative tools. By focusing on the window between biomarker elevation and clinical diagnosis, Boshoven’s research offers a pathway to earlier intervention and improved patient outcomes. His findings have implications not only for urological oncology but also for the broader field of nephrology, where timely AKI detection remains a persistent challenge. Through this targeted, translational approach, Boshoven is helping to refine risk stratification and postoperative care for vulnerable surgical populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
20 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Spectrum Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago